News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Inc. (ESALF.PK) Gets Approval for Anti-seizure Drug


7/27/2012 7:27:40 AM

Eisai Co. announced July 27 that its U.K. subsidiary, Eisai Europe Ltd., has received approval from the European Commission (EC) to market a new type of anti-epileptic drug. The drug perampanel, marketed as Fycompa, is the first in a new class of treatment for epilepsy to be approved by the EC. The drug works as an adjunctive, or add-on, treatment for partial-onset seizures in people with epilepsy aged 12 and older.

Read at News Release

comments powered by Disqus
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES